Opinion: The Growing Fang-to-Pharmacy Pipeline

Powerful therapeutic compounds derived from animal venoms and toxins represent a largely untapped resource for developing new medications. Researchers are increasingly investigating bioactive molecules from venomous creatures—snakes, spiders, scorpions, and other organisms—to create treatments for various diseases. This emerging field, sometimes called venom-derived drug development, has already produced FDA-approved medications and shows significant promise for conditions ranging from chronic pain to cancer. By shifting perspective on creatures traditionally feared, scientists are discovering that nature's most potent toxins may become medicine's most valuable tools.